Autonomix Medical (AMIX) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $2.85, -2.90% vs the prior close of $2.93.
- Volume 30.24K shares, 0.0x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
AMIX dips 2.9% to $2.85, a 1-month low. Closed at $2.85, -2.90% vs the prior close of $2.93. Day range $2.80–$3.00, opened at $2.93.
AMIX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — AMIX dips 2.9% to $2.85, a 1-month low
- Closed at $2.85, -2.90% vs the prior close of $2.93. Day range $2.80–$3.00, opened at $2.93.
- Volume was 30.24K shares, 0.0x its 50-day average of 1.17M — lighter than usual.
- Price is -41.2% vs its 50-day average ($4.84) and -60.6% vs its 200-day average ($7.22).
- 52-week range $2.44–$32.55; today's close sits at 1% of that range, 91.3% below the 52-week high.
Oct 15, 2026 — AMIX rises 1.0% to $2.93
- Closed at $2.93, +1.03% vs the prior close of $2.90. Day range $2.81–$2.96, opened at $2.89.
- Volume was 31.80K shares, 0.0x its 50-day average of 1.46M — lighter than usual.
- Price is -41.7% vs its 50-day average ($5.02) and -59.7% vs its 200-day average ($7.27).
- 52-week range $2.44–$32.55; today's close sits at 2% of that range, 91.0% below the 52-week high.
Oct 14, 2026 — AMIX slides 3.7% to $2.90, a 1-month low, 9 down days in a row
- Closed at $2.90, -3.65% vs the prior close of $3.01. Day range $2.90–$3.07, opened at $3.03.
- Volume was 56.40K shares, 0.0x its 50-day average of 3.85M — lighter than usual.
- Price is -44.3% vs its 50-day average ($5.21) and -60.3% vs its 200-day average ($7.31).
- 52-week range $2.44–$32.55; today's close sits at 2% of that range, 91.1% below the 52-week high.
- That makes 9 straight losses.
Oct 13, 2026 — AMIX dips 2.9% to $3.01, a 1-month low, 8 down days in a row
- Closed at $3.01, -2.90% vs the prior close of $3.10. Day range $3.00–$3.16, opened at $3.09.
- Volume was 30.80K shares, 0.0x its 50-day average of 3.86M — lighter than usual.
- Price is -45.6% vs its 50-day average ($5.54) and -59.1% vs its 200-day average ($7.35).
- 52-week range $2.44–$32.55; today's close sits at 2% of that range, 90.8% below the 52-week high.
- That makes 8 straight losses.
Oct 12, 2026 — AMIX dips 0.3% to $3.10, a 1-month low, 7 down days in a row
- Closed at $3.10, -0.32% vs the prior close of $3.11. Day range $3.10–$3.19, opened at $3.13.
- Volume was 41.90K shares, 0.0x its 50-day average of 3.87M — lighter than usual.
- Price is -44.2% vs its 50-day average ($5.55) and -58.1% vs its 200-day average ($7.40).
- 52-week range $2.44–$32.55; today's close sits at 2% of that range, 90.5% below the 52-week high.
- That makes 7 straight losses.
Oct 9, 2026 — AMIX dips 0.6% to $3.11, a 1-month low, 6 down days in a row
- Closed at $3.11, -0.64% vs the prior close of $3.13. Day range $3.08–$3.17, opened at $3.10.
- Volume was 33.10K shares, 0.0x its 50-day average of 3.89M — lighter than usual.
- Price is -44.0% vs its 50-day average ($5.56) and -58.2% vs its 200-day average ($7.45).
- 52-week range $2.44–$32.55; today's close sits at 2% of that range, 90.4% below the 52-week high.
- That makes 6 straight losses.
Oct 8, 2026 — AMIX slides 8.2% to $3.13, a 1-month low, 5 down days in a row
- Closed at $3.13, -8.21% vs the prior close of $3.41. Day range $3.10–$3.40, opened at $3.40.
- Volume was 87.10K shares, 0.0x its 50-day average of 5.29M — lighter than usual.
- Price is -43.8% vs its 50-day average ($5.57) and -58.3% vs its 200-day average ($7.50).
- 52-week range $2.44–$32.55; today's close sits at 2% of that range, 90.4% below the 52-week high.
- That makes 5 straight losses.
Oct 7, 2026 — AMIX dips 1.7% to $3.41, a 1-month low, 4 down days in a row
- Closed at $3.41, -1.73% vs the prior close of $3.47. Day range $3.39–$3.59, opened at $3.49.
- Volume was 56.20K shares, 0.0x its 50-day average of 5.50M — lighter than usual.
- Price is -39.1% vs its 50-day average ($5.60) and -54.8% vs its 200-day average ($7.55).
- 52-week range $2.44–$32.55; today's close sits at 3% of that range, 89.5% below the 52-week high.
- That makes 4 straight losses.
Oct 6, 2026 — AMIX dips 2.0% to $3.47, a 1-month low, 3 down days in a row
- Closed at $3.47, -1.98% vs the prior close of $3.54. Day range $3.45–$3.60, opened at $3.54.
- Volume was 63.30K shares, 0.0x its 50-day average of 5.51M — lighter than usual.
- Price is -37.8% vs its 50-day average ($5.58) and -54.3% vs its 200-day average ($7.60).
- 52-week range $2.44–$32.55; today's close sits at 3% of that range, 89.3% below the 52-week high.
- That makes 3 straight losses.
Oct 5, 2026 — AMIX slides 6.3% to $3.54, a 1-month low
- Closed at $3.54, -6.35% vs the prior close of $3.78. Day range $3.54–$3.73, opened at $3.68.
- Volume was 133.30K shares, 0.0x its 50-day average of 5.67M — lighter than usual.
- Price is -36.4% vs its 50-day average ($5.57) and -53.7% vs its 200-day average ($7.65).
- 52-week range $2.44–$32.55; today's close sits at 4% of that range, 89.1% below the 52-week high.
Oct 2, 2026 — AMIX slides 3.6% to $3.78
- Closed at $3.78, -3.57% vs the prior close of $3.92. Day range $3.62–$4.04, opened at $3.99.
- Volume was 2.57M shares, 0.5x its 50-day average of 5.64M — lighter than usual.
- Price is -32.0% vs its 50-day average ($5.56) and -50.9% vs its 200-day average ($7.69).
- 52-week range $2.44–$32.55; today's close sits at 4% of that range, 88.4% below the 52-week high.
AMIX latest news & SEC filings
Every SEC filing by or about AMIX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 13, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Sep 21, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Smith Trent N. received an award of 15,000 shares on Sep 3, 2026; now holds 15,119
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 16, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 16, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Sep 15, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Sep 14, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Sep 14, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Sep 11, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 4, 2026 · Form PRE 14A — Preliminary proxy statement
Preliminary proxy statement
Sep 4, 2026 · Form S-3 — Shelf registration (S-3)
Shelf registration (S-3) — lets the company sell securities over time
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 26, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 3.02 — Sold unregistered shares.
- Item 8.01 — Reported other events the company considers important.
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $0 (prior year $0)
- Net income: -$2.73M (prior year -$3.34M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$5.02 (prior year -$22.69) (loss narrowed vs Jun 30, 2025)
Things to know before you trade AMIX
- Last results release: Feb 13, 2025 (8-K Item 2.02). Previous ones: Nov 12, 2024, Aug 13, 2024, May 31, 2024. Based on that rhythm, the next report is likely around May 15, 2025 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.87% (largest 8.2%).
- Liquidity: about 215.31K shares (≈$612.56K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $2.85 vs a range of $2.44–$32.55 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:21 on Jun 24, 2026, 1:20 on Oct 25, 2024
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Sep 16, 2026; 8-K Aug 26, 2026; 10-Q Aug 13, 2026.
- Share count: 971.04K shares outstanding (Aug 6, 2026), -81.1% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
AMIX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 2.93 | 3.00 | 2.80 | 2.85 | 30.24K |
| Oct 15, 2026 | 2.89 | 2.96 | 2.81 | 2.93 | 31.80K |
| Oct 14, 2026 | 3.03 | 3.07 | 2.90 | 2.90 | 56.40K |
| Oct 13, 2026 | 3.09 | 3.16 | 3.00 | 3.01 | 30.80K |
| Oct 12, 2026 | 3.13 | 3.19 | 3.10 | 3.10 | 41.90K |
| Oct 9, 2026 | 3.10 | 3.17 | 3.08 | 3.11 | 33.10K |
| Oct 8, 2026 | 3.40 | 3.40 | 3.10 | 3.13 | 87.10K |
| Oct 7, 2026 | 3.49 | 3.59 | 3.39 | 3.41 | 56.20K |
| Oct 6, 2026 | 3.54 | 3.60 | 3.45 | 3.47 | 63.30K |
| Oct 5, 2026 | 3.68 | 3.73 | 3.54 | 3.54 | 133.30K |
| Oct 2, 2026 | 3.99 | 4.04 | 3.62 | 3.78 | 2.57M |
| Oct 1, 2026 | 3.84 | 4.20 | 3.80 | 3.92 | 133.30K |
| Sep 30, 2026 | 3.83 | 3.91 | 3.60 | 3.83 | 401.80K |
| Sep 29, 2026 | 3.87 | 3.88 | 3.73 | 3.75 | 47.50K |
| Sep 28, 2026 | 3.80 | 3.94 | 3.77 | 3.83 | 74.20K |
| Sep 25, 2026 | 4.09 | 4.30 | 3.91 | 4.02 | 262.80K |
| Sep 24, 2026 | 4.05 | 4.18 | 3.94 | 4.07 | 47.90K |
| Sep 23, 2026 | 4.11 | 4.11 | 3.90 | 3.98 | 55.20K |
| Sep 22, 2026 | 4.00 | 4.22 | 4.00 | 4.13 | 60.90K |
| Sep 21, 2026 | 4.13 | 4.29 | 3.91 | 4.05 | 83.80K |
About Autonomix Medical
Autonomix Medical (AMIX) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in THE WOODLANDS, TX. State of incorporation: DE. Fiscal year ends March 31. SEC CIK 1617867.
AMIX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Lori Bisson | Director | Sep 8, 2026 |
| Walter V Klemp | Director | Sep 8, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Bradley Hauser | CEO and President | Sep 8, 2026 |
| Trent N. Smith | CFO | Sep 21, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
AMIX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Mar 31, 2026 | $0 | $-16.71M | -2.32 | $-12.28M |
| Mar 31, 2025 | $0 | $-11.41M | -6.46 | $-8.26M |
| Mar 31, 2024 | $0 | $-15.43M | -14.82 | $-6.60M |
| Mar 31, 2023 | $0 | $-1.99M | -0.17 | $-1.85M |
Latest balance sheet: total assets $3.98M, total liabilities $818.00K, cash $3.46M (as of Jun 30, 2026).
AMIX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Feb 13, 2025 | 8-K Item 2.02 (results) | $59.85 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $222.60 |
| Aug 13, 2024 | 8-K Item 2.02 (results) | — |
| May 31, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on AMIX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.